Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XDDNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDDNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.53NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.53NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.53NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.60NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.60NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.60NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.6.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.6.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.6.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.28NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
P.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
P.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
P.2 (Zeta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
P.2 (Zeta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.2 (Zeta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.33NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.33NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
N.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
N.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.499NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.499NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.499NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
N.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
N.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.212NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.212NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.212NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.61NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.61NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.61NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.16.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.86NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.86NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.86NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used